66 assets in Adult Acute Lymphoblastic Leukemia

Therapeutic assets addressing Adult Acute Lymphoblastic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
19-28z/il-18 car t cells Adult Acute Lymphoblastic Leukemia	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Allogeneic Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T-Lymphocytes Adult Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	CC (43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes Adult Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	CC (43)
cc312 Adult Acute Lymphoblastic Leukemia	CytoCares Inc	P1	CC (43)
CD19.CAR-aNKT cells Adult Acute Lymphoblastic Leukemia	Baylor College of Medicine	P1	CC (43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Adult Acute Lymphoblastic Leukemia	Fred Hutchinson Cancer Center	P1	CC (43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes Adult Acute Lymphoblastic Leukemia	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Tsc-100 Adult Acute Lymphoblastic Leukemia	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-101 Adult Acute Lymphoblastic Leukemia	TScan Therapeutics, Inc.	P1	CC (43)
Hyaluronidase Fihj Adult Acute Lymphoblastic Leukemia	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Early P1	C (39)
lv009 Adult Acute Lymphoblastic Leukemia	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Early P1	C (39)
2vip Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	N/A	D (30)
Senl_B19 Autologous Car-T Treatment Adult Acute Lymphoblastic Leukemia	Peking University People's Hospital	N/A	D (30)

Showing 51 to 66 of 66 assets

PreviousPage 2 of 2Next